Search
forCommunity 10 of 58
- Is there any role for topical DHT antagonists, or does a 5-AR inhibitor remove the need for them as therapy
- EMA is re-examining Winlevi (clascoterone at lower concentration)
- Fagron TrichoTest says Finasteride won't help
- Will finasteride halt my beard development ?
- Question about clascoterone acne cream
- Pyrilutamide just launched internationally, and all you're doing is hating
- Kintor's email response to me, regarding false advertising, and my proposal for them to develop a topical dut formulation with meaningful efficacy.
- Why are there no FDA approved NSAA's yet?
- PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
- To everyone who cant use FIN and doesnt want to use RU
Research 10 of 1000+
- Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- Androgen Receptor Ligands: Agonists and Antagonists
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
Learn
— no results
Try a deeper search in learn →